Log in to save to my catalogue

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controver...

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controver...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6788885

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies

About this item

Full title

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies

Publisher

England: BMJ Publishing Group Ltd and European League Against Rheumatism

Journal title

Annals of the rheumatic diseases, 2019-09, Vol.78 (9), p.1167-1178

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd and European League Against Rheumatism

More information

Scope and Contents

Contents

Although the pathogenic mechanisms underlying axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) are not fully elucidated, several lines of evidence suggest that immune responses mediated by interleukin 17A (IL-17A) play a pivotal role in both diseases. This is best highlighted by the significant clinical efficacy shown with inhibitors o...

Alternative Titles

Full title

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6788885

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6788885

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2019-215356

How to access this item